Once everyone’s had enough of injections, side effects, and the vast expense of GLP-1 drugs, it could be natural alternatives ...

Structure Therapeutics Inc. (NASDAQ: GPCR), a biopharmaceutical company specializing in the development of oral treatments for diabetes and obesity, has been making waves in the competitive GLP-1 ...

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management ...

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

TMates offers a structured weight loss program built around GLP-1 therapy, created by a team of licensed healthcare ...

An Ozempic user has revealed one unexpected side effect that's 'causing issues in their relationship'. While many people are having a lot of success taking GLP-1 drugs such as Ozempic, Mounjaro and ...

July kicks off the latter half of 2025, and the first six months of this year have been eventful, to say the least. Yet, the ...

In today’s world, losing weight isn’t just about fitting into your old jeans—it’s about reclaiming your energy, confidence, ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could eventually be an alternative or add-on to popular GLP-1 medications.